NEJM Editorialists: Sentinel System Feasible, But Presents Challenges
This article was originally published in The Gray Sheet
Executive Summary
FDA's post-market surveillance Sentinel Initiative comes with some steep challenges, several health policy experts write in the New England Journal of Medicine July 27
You may also be interested in...
Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale
FDA's new "mini-Sentinel" project fulfills a statutory requirement to establish a national post-market drug safety surveillance system linking data on 25 million patients by July 1, but will not track device data for at least the first year, the agency says
Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale
FDA's new "mini-Sentinel" project fulfills a statutory requirement to establish a national post-market drug safety surveillance system linking data on 25 million patients by July 1, but will not track device data for at least the first year, the agency says
FDA Struggles To Create A User-Friendly Device Identification System
The hardest part about establishing a mandatory unique identification system for devices is crafting one that all users - from manufacturers to distributors to hospitals - will be able to implement, FDA says